Accountant. To the Company’s knowledge, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Inc., which has expressed its opinion with respect to the Company’s financial statements as of December 31, 2017 and 2016, respectively, and included in the SEC Reports (including the related notes), is an independent registered public accounting firm as required by the Act and the Public Company Accounting Oversight Board (United States). ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Inc. have not been engaged by the Company to perform any “prohibited activities” (as defined in Section 10A of the Exchange Act).
Appears in 3 contracts
Sources: Securities Purchase Agreement (Second Sight Medical Products Inc), Securities Purchase Agreement (Second Sight Medical Products Inc), Securities Purchase Agreement (Second Sight Medical Products Inc)
Accountant. To the Company’s knowledge, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Inc., which has expressed its opinion with respect to the Company’s financial statements as of December 31, 2017 2016 and 20162015, respectively, and included in the SEC Reports (including the related notes), is an independent registered public accounting firm as required by the Act and the Public Company Accounting Oversight Board (United States). ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Inc. have not been engaged by the Company to perform any “prohibited activities” (as defined in Section 10A of the Exchange Act).
Appears in 2 contracts
Sources: Securities Purchase Agreement (Duggan Robert W), Securities Purchase Agreement (Pulse Biosciences, Inc.)
Accountant. To the Company’s knowledge, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Inc., which has expressed its opinion with respect to the Company’s financial statements as of December 31, 2017 2015 and 20162014, respectively, and included in the SEC Reports (including the related notes), is an independent registered public accounting firm as required by the Act and the Public Company Accounting Oversight Board (United States). ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Inc. have not been engaged by the Company to perform any “prohibited activities” (as defined in Section 10A of the Exchange Act).
Appears in 1 contract
Sources: Securities Purchase Agreement (Pulse Biosciences, Inc.)
Accountant. To the Company’s knowledge, ▇G▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Inc., which has expressed its opinion with respect to the Company’s financial statements as of December 31, 2017 and 2016, respectively, and included in the SEC Reports (including the related notes), is an independent registered public accounting firm as required by the Act and the Public Company Accounting Oversight Board (United States). ▇G▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Inc. have not been engaged by the Company to perform any “prohibited activities” (as defined in Section 10A of the Exchange Act).
Appears in 1 contract
Sources: Securities Purchase Agreement (Second Sight Medical Products Inc)